TriSalus Life Sciences (TLSI) FCF Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) reported FCF Margin of 74.4% for Q1 2026, down 1710.0% on a YoY basis from 4.62% in Q1 2025, and down 294.73% quarter-over-quarter from 18.85% in Q4 2025.
TriSalus Life Sciences (TLSI) FCF Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences has reported FCF Margin for 5 years, with the latest figure at 74.4% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 1710.0% year-over-year to 74.4%; the trailing twelve-month figure through Mar 2026 stood at 43.33% (up 6735.0% YoY), and the FY2025 full-year result was 40.04%, up 9990.0% from the prior year.
- FCF Margin for Q1 2026 stood at 74.4%, down from 18.85% in the prior quarter.
- The five-year high for FCF Margin was 18.85% in Q4 2025, with the low at 583.23% in Q3 2022.
- Historically, FCF Margin has averaged 186.73% across 5 years, with a median of 166.91% in 2023.
- Annual changes were most pronounced in 2024 — FCF Margin surged 27297 bps — and 2026, when it sank 1710 bps.
- TriSalus Life Sciences' FCF Margin stood at 263.92% in 2022, then surged by 37 bps to 166.91% in 2023, then soared by 56 bps to 73.26% in 2024, then jumped by 74 bps to 18.85% in 2025, then tumbled by 295 bps to 74.4% in 2026.
- The last three FCF Margin figures came in at 74.4% (Q1 2026), 18.85% (Q4 2025), and 32.44% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | TriSalus Life Sciences | 209.25 Mn | 152.70 Mn | 7.67 Mn | -74.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.40% |
| Dec 31, 2025 | -18.85% |
| Sep 30, 2025 | -32.44% |
| Jun 30, 2025 | -58.74% |
| Mar 31, 2025 | -57.30% |
| Dec 31, 2024 | -73.26% |
| Sep 30, 2024 | -147.60% |
| Jun 30, 2024 | -182.27% |
| Mar 31, 2024 | -168.30% |
| Dec 31, 2023 | -166.91% |
| Sep 30, 2023 | -420.57% |
| Jun 30, 2023 | -200.93% |
| Mar 31, 2023 | -352.21% |
| Dec 31, 2022 | -263.92% |
| Sep 30, 2022 | -583.23% |